Elaine J. Heron

Director, Vaxart.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jul 16, 2026Granted 39,400 shares of Vaxart⁶
Feb 27, 2026Bought 2,400 shares at $125.00 of PALVELLA THERAPEUTICS, INC.⁴
Nov 17, 2025Bought 16,783 shares at $0.41 of Vaxart⁷
Nov 17, 2025Bought 23,217 shares at $0.39 of Vaxart⁷
Jun 13, 2025Granted 16,000 shares of Vaxart⁸
Jun 11, 2024Granted 16,000 shares of Vaxart⁹
Jun 3, 2024Shares withheld for tax 4,168 shares at $76.41 of BioMarin Pharmaceutical⁵
Jun 3, 2024Exercised options 5,047 shares at $63.10 of BioMarin Pharmaceutical⁵
May 21, 2024Granted 4,720 shares of BioMarin Pharmaceutical¹⁰
Jun 26, 2023Granted 6,922 shares of Vaxart¹¹
May 23, 2023Granted 4,190 shares of BioMarin Pharmaceutical¹²
May 12, 2023Shares withheld for tax 6,137 shares at $93.93 of BioMarin Pharmaceutical¹³
May 12, 2023Exercised options 8,500 shares at $67.81 of BioMarin Pharmaceutical¹³
Aug 25, 2022Granted 14,750 shares of Vaxart¹⁴
May 24, 2022Granted 4,980 shares of BioMarin Pharmaceutical¹⁵
Feb 25, 2022Exercised options 8,500 shares at $37.46 of BioMarin Pharmaceutical¹⁶

Date	Stock	Trade	Value	Return since	Vs S&P since	Vs S&P, 1 year
Nov 17, 2025	VXRT	Buy	$15.9K	+17.9%	+2.0%

Returns are price-only (no dividends), measured from the trade date.

The numbers on this page point here. Each one links to the record it came from.